Wong T, Devlin J, Rolando N, Heaton N, Williams R
Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Transplantation. 1997 Sep 27;64(6):878-82. doi: 10.1097/00007890-199709270-00015.
The outcome of retransplantation remains unsatisfactory when compared with primary transplantation of the liver. The aim of the present study was to determine which preoperative clinical and laboratory risk variables are implicated in the poorer outcome.
The preoperative status of 70 retransplanted patients was compared with a group of 303 time-matched recipients receiving their first graft.
Survival at 1 year was reduced in the retransplant versus the primary transplant group (50% vs. 80%, P<0.001). Preoperatively older age, high United Network of Organ Sharing score, inpatient status, elevated bilirubin, and creatinine levels were associated with increased mortality after a second transplant. Preoperatively, the retransplant group had higher encephalopathy grades, were more likely to be inpatients, and had higher serum creatinine, bilirubin, and white cell levels than the primary recipients (P<0.05 in all cases). The median length of inpatient stay was longer after the second transplant (25 vs. 19 days, P<0.001).
These factors assist in the stratification of patients awaiting retransplantation; however, the outcome of this procedure is only likely to be improved with an earlier identification of the patients who require it, along with an increased priority in organ allocation.
与肝脏初次移植相比,再次移植的结果仍不尽人意。本研究的目的是确定哪些术前临床和实验室风险变量与较差的结果相关。
将70例再次移植患者的术前状况与一组303例接受首次移植且时间匹配的受者进行比较。
再次移植组1年生存率低于初次移植组(50%对80%,P<0.001)。术前年龄较大、器官共享联合网络评分较高、住院状态、胆红素和肌酐水平升高与二次移植后死亡率增加相关。术前,再次移植组的脑病分级更高,更有可能是住院患者,血清肌酐、胆红素和白细胞水平高于初次移植受者(所有情况P<0.05)。二次移植后的住院中位时间更长(25天对19天,P<0.001)。
这些因素有助于对等待再次移植的患者进行分层;然而,只有更早地识别需要再次移植的患者,并提高器官分配的优先级,才有可能改善该手术的结果。